| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Diseases | 6 | 2024 | 320 | 1.440 |
Why?
|
| Kidney Neoplasms | 5 | 2023 | 523 | 1.170 |
Why?
|
| Kidney | 9 | 2023 | 1148 | 1.040 |
Why?
|
| Nephrectomy | 4 | 2023 | 291 | 0.940 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2020 | 23 | 0.820 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2023 | 333 | 0.810 |
Why?
|
| Diabetic Nephropathies | 2 | 2020 | 87 | 0.730 |
Why?
|
| Acute Kidney Injury | 3 | 2020 | 316 | 0.710 |
Why?
|
| Nephrosclerosis | 1 | 2020 | 5 | 0.690 |
Why?
|
| Arteriosclerosis | 1 | 2020 | 112 | 0.670 |
Why?
|
| Glomerulonephritis | 3 | 2020 | 76 | 0.620 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 222 | 0.570 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 203 | 0.550 |
Why?
|
| Kidney Glomerulus | 4 | 2022 | 122 | 0.480 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 3 | 2022 | 35 | 0.440 |
Why?
|
| Incidental Findings | 2 | 2019 | 98 | 0.440 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2019 | 952 | 0.430 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 2015 | 21 | 0.390 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2010 | 159 | 0.330 |
Why?
|
| Kidney Failure, Chronic | 2 | 2024 | 414 | 0.300 |
Why?
|
| Pathology, Surgical | 1 | 2007 | 12 | 0.300 |
Why?
|
| Kidney Transplantation | 3 | 2019 | 855 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 160 | 0.270 |
Why?
|
| Biomarkers, Tumor | 4 | 2019 | 1542 | 0.260 |
Why?
|
| Autopsy | 3 | 2024 | 122 | 0.240 |
Why?
|
| Allografts | 3 | 2019 | 184 | 0.230 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 401 | 0.220 |
Why?
|
| Cause of Death | 2 | 2024 | 269 | 0.210 |
Why?
|
| Humans | 26 | 2024 | 89864 | 0.200 |
Why?
|
| Biopsy | 7 | 2021 | 1184 | 0.200 |
Why?
|
| Aged | 9 | 2020 | 19230 | 0.200 |
Why?
|
| Complement C4b | 1 | 2021 | 32 | 0.180 |
Why?
|
| Lupus Nephritis | 1 | 2021 | 77 | 0.180 |
Why?
|
| Female | 17 | 2022 | 46529 | 0.180 |
Why?
|
| Atypical Hemolytic Uremic Syndrome | 1 | 2020 | 3 | 0.180 |
Why?
|
| Adult | 14 | 2020 | 26784 | 0.180 |
Why?
|
| Proteinuria | 1 | 2020 | 67 | 0.180 |
Why?
|
| Receptors, Interleukin-2 | 3 | 2004 | 67 | 0.170 |
Why?
|
| Middle Aged | 10 | 2020 | 26103 | 0.170 |
Why?
|
| Neurofibromatosis 2 | 1 | 2019 | 11 | 0.170 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 21 | 0.170 |
Why?
|
| Optical Imaging | 1 | 2020 | 51 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 212 | 0.170 |
Why?
|
| Sampling Studies | 1 | 2019 | 72 | 0.170 |
Why?
|
| Integrin beta3 | 1 | 2019 | 32 | 0.160 |
Why?
|
| Thrombosis | 2 | 2015 | 302 | 0.160 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2019 | 55 | 0.160 |
Why?
|
| Graft Rejection | 3 | 2021 | 1076 | 0.160 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2018 | 16 | 0.150 |
Why?
|
| Bowman Capsule | 1 | 2018 | 6 | 0.150 |
Why?
|
| Nephritis | 1 | 2018 | 17 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2007 | 1062 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2020 | 130 | 0.150 |
Why?
|
| Rectal Neoplasms | 1 | 2019 | 129 | 0.150 |
Why?
|
| Eosinophilia | 1 | 2018 | 84 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 178 | 0.140 |
Why?
|
| Terminology as Topic | 1 | 2018 | 222 | 0.140 |
Why?
|
| Adenoma | 1 | 2019 | 250 | 0.140 |
Why?
|
| Heart Transplantation | 2 | 2021 | 728 | 0.130 |
Why?
|
| Male | 10 | 2022 | 42614 | 0.130 |
Why?
|
| Hemoglobin C Disease | 1 | 2015 | 5 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2018 | 1221 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3670 | 0.130 |
Why?
|
| JC Virus | 1 | 2015 | 5 | 0.130 |
Why?
|
| Sialic Acids | 1 | 2015 | 18 | 0.130 |
Why?
|
| Choroid Plexus | 1 | 2015 | 14 | 0.130 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2015 | 7 | 0.130 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Kidney Medulla | 1 | 2015 | 80 | 0.120 |
Why?
|
| Receptors, Virus | 1 | 2015 | 75 | 0.120 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2015 | 7 | 0.120 |
Why?
|
| Survival Rate | 1 | 2019 | 1898 | 0.120 |
Why?
|
| Melanoma | 1 | 2019 | 471 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2015 | 91 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2015 | 84 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2015 | 86 | 0.120 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 425 | 0.120 |
Why?
|
| Hemolysis | 1 | 2014 | 64 | 0.120 |
Why?
|
| Kidney Tubules | 1 | 2014 | 92 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2008 | 276 | 0.110 |
Why?
|
| Risk Factors | 3 | 2020 | 5548 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2014 | 193 | 0.110 |
Why?
|
| Young Adult | 4 | 2020 | 6389 | 0.110 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 144 | 0.110 |
Why?
|
| CD28 Antigens | 2 | 2003 | 90 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 469 | 0.110 |
Why?
|
| HIV Infections | 1 | 2022 | 847 | 0.110 |
Why?
|
| Neurilemmoma | 1 | 2013 | 34 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2015 | 250 | 0.100 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2004 | 449 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 6779 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 98 | 0.100 |
Why?
|
| Adolescent | 4 | 2019 | 9327 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 1183 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2019 | 2324 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 449 | 0.090 |
Why?
|
| Disease Progression | 2 | 2018 | 1469 | 0.090 |
Why?
|
| Mutation | 2 | 2020 | 4164 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2010 | 231 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 1130 | 0.090 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 1799 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 684 | 0.080 |
Why?
|
| Leukosialin | 1 | 2008 | 16 | 0.080 |
Why?
|
| Ureter | 1 | 2009 | 95 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 1729 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2024 | 337 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2301 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2008 | 166 | 0.070 |
Why?
|
| Th2 Cells | 1 | 2008 | 147 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2008 | 395 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2007 | 281 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 2368 | 0.070 |
Why?
|
| B7-1 Antigen | 2 | 2003 | 76 | 0.070 |
Why?
|
| CD3 Complex | 2 | 2003 | 134 | 0.060 |
Why?
|
| Brain | 1 | 2015 | 2303 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2004 | 83 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 141 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 977 | 0.060 |
Why?
|
| Autoantigens | 1 | 2004 | 129 | 0.050 |
Why?
|
| Pathologists | 1 | 2023 | 29 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2024 | 9185 | 0.050 |
Why?
|
| Inflammation | 1 | 2008 | 981 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 326 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 2000 | 0.050 |
Why?
|
| Chicago | 2 | 2018 | 1431 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2021 | 87 | 0.050 |
Why?
|
| Homeostasis | 1 | 2003 | 418 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2004 | 312 | 0.050 |
Why?
|
| Biomarkers | 2 | 2020 | 1774 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2002 | 173 | 0.050 |
Why?
|
| Mice, Inbred NOD | 3 | 2008 | 198 | 0.050 |
Why?
|
| Complement Factor B | 1 | 2020 | 9 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 13 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 169 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 1054 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2021 | 323 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2018 | 8264 | 0.040 |
Why?
|
| Complement Factor H | 1 | 2020 | 34 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2004 | 1576 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 1394 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 2649 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2020 | 147 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2004 | 565 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 236 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2019 | 70 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 463 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2019 | 150 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 665 | 0.040 |
Why?
|
| Antigens, CD | 3 | 2004 | 466 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 569 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 995 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2018 | 529 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2004 | 1091 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 864 | 0.030 |
Why?
|
| Mice | 6 | 2008 | 11846 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1607 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 4 | 2004 | 3250 | 0.030 |
Why?
|
| Sickle Cell Trait | 1 | 2015 | 21 | 0.030 |
Why?
|
| Microvessels | 1 | 2015 | 69 | 0.030 |
Why?
|
| Astrocytes | 1 | 2015 | 142 | 0.030 |
Why?
|
| Oligodendroglia | 1 | 2015 | 124 | 0.030 |
Why?
|
| Rituximab | 1 | 2015 | 117 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 490 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2004 | 2015 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 301 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 277 | 0.030 |
Why?
|
| B7-2 Antigen | 2 | 2003 | 40 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 270 | 0.030 |
Why?
|
| NIMA-Related Kinases | 1 | 2013 | 7 | 0.030 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2013 | 10 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3765 | 0.030 |
Why?
|
| Pregnancy | 1 | 2020 | 3040 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 126 | 0.030 |
Why?
|
| Phenotype | 1 | 2018 | 2450 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2002 | 3403 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 431 | 0.020 |
Why?
|
| Animals | 6 | 2008 | 27516 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 399 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2887 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1532 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 2360 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2008 | 36 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2008 | 41 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2008 | 48 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 231 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 145 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 129 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1452 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2008 | 169 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 5357 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 602 | 0.020 |
Why?
|
| L-Selectin | 1 | 2004 | 16 | 0.020 |
Why?
|
| Lymphocyte Subsets | 1 | 2004 | 66 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2004 | 140 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 155 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 169 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 1179 | 0.010 |
Why?
|
| Child | 1 | 2015 | 7233 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 53 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 793 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2003 | 31 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2003 | 241 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2003 | 98 | 0.010 |
Why?
|
| fas Receptor | 1 | 2003 | 77 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 885 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2003 | 197 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2002 | 23 | 0.010 |
Why?
|
| Spleen | 1 | 2003 | 433 | 0.010 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2002 | 34 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2002 | 36 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2002 | 54 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 692 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1669 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 81 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2002 | 160 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 194 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 983 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 583 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2003 | 550 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1130 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 754 | 0.010 |
Why?
|
| Graft Survival | 1 | 2003 | 907 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 1717 | 0.010 |
Why?
|